Effects of Cardiac Rehabilitation on Postoperatory of Coronary Artery Bypass Graft.

NCT ID: NCT01410253

Last Updated: 2016-03-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-01-31

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomized Clinical Trial to evaluate the use of different techniques of physical therapy on recovery of functional capacity, pulmonary function and respiratory muscle strength in the period of hospital stay after coronary artery bypass graft.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Complication of CABG

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Group Type EXPERIMENTAL

Combination of four techniques of physiotherapy

Intervention Type OTHER

The patients receive conventional physiotherapy, expiratory positive airway pressure, inspiratory muscle training and physical exercise. Twice daily for seven days

Group 2

Group Type EXPERIMENTAL

Combination of three techniques of physiotherapy

Intervention Type OTHER

Patients receive conventional physiotherapy, expiratory positive airway pressure and physical exercise. Twice daily for seven days

Group 3

Group Type EXPERIMENTAL

Combination of two techniques of physiotherapy

Intervention Type OTHER

Patients receive conventional physiotherapy,expiratory positive airway pressure respiratory muscle training. Twice daily for seven days

Group 4

Group Type PLACEBO_COMPARATOR

standard therapy

Intervention Type OTHER

Patients receive conventional physiotherapy and expiratory positive airway pressure. Twice daily for seven days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Combination of four techniques of physiotherapy

The patients receive conventional physiotherapy, expiratory positive airway pressure, inspiratory muscle training and physical exercise. Twice daily for seven days

Intervention Type OTHER

Combination of three techniques of physiotherapy

Patients receive conventional physiotherapy, expiratory positive airway pressure and physical exercise. Twice daily for seven days

Intervention Type OTHER

Combination of two techniques of physiotherapy

Patients receive conventional physiotherapy,expiratory positive airway pressure respiratory muscle training. Twice daily for seven days

Intervention Type OTHER

standard therapy

Patients receive conventional physiotherapy and expiratory positive airway pressure. Twice daily for seven days

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

-Patients are recruited from the waiting list for a first CABG intervention at the Porto Alegre Clinical Hospital.

Exclusion Criteria

* chronic renal failure,
* unstable angina,
* moderate or severe valve disease,
* complex cardiac arrhythmia,
* stroke,
* inability to exercise the lower limbs,
* subjects with forced expiratory volume in 1 second less than 70% of predicted
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital de Clinicas de Porto Alegre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maurice Zanini

Msc.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Porto Alegre Clinical Hospital

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GPPG090650

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.